Shares of Eli Lilly (NYSE: LLY) fell sharply on Thursday, dropping more than 11% in regular trading after the company […]
Eli Lilly (NYSE: LLY) Warns of Lower Profits in 2025, Stock Tumbles Read More »
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from
US FDA Revokes Authorization for Four COVID Antibody Drugs Read More »
On Friday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) weight-loss treatment, Zepbound, for obstructive sleep apnea,
Lilly’s Weight-Loss Drug Zepbound Wins US FDA Approval for Sleep Apnea Read More »
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies Read More »
LONDON – Britons paying privately for obesity drugs are increasingly choosing Eli Lilly’s (NYSE: LLY) Mounjaro over Novo Nordisk’s (NYSE:
Lilly’s Mounjaro Gains Market Share Over Wegovy in UK’s Private Obesity Drug Market Read More »
President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) as
Trump, RFK Jr. Met with Pfizer, Lilly Executives: Report Read More »
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
Novo, Lilly Shares Rise as Biden Proposes Obesity Care Coverage Read More »
Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles Read More »
NEW YORK – Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk (NYSE: NVO) and
US Medicaid Programs Say Cost a Key Factor for Weight-Loss Drug Coverage, Survey Finds Read More »
LONDON – Britain will study whether the use of Eli Lilly’s (NYSE: LLY) weight loss drug can get people back
Britain to Study Use of Lilly’s Weight Loss Drug to Get People Back to Work Read More »
On Monday, a drug compounding industry group sued the U.S. Food and Drug Administration over its decision to take Eli
Compounding Group Sues FDA Over Removal of Lilly’s Weight Loss Drug from Shortage List Read More »
Eli Lilly (NYSE: LLY) is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely
Eli Lilly (NYSE: LLY) Invests $1.8 Billion to Expand Production of Key Drugs in Ireland Read More »
The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business
Weight-Loss Market to See 16 New Drugs by 2029: Report Read More »
On Tuesday, Eli Lilly (NYSE: LLY) said it has begun selling vials of the lowest starter dose of its popular
Eli Lilly’s (NYSE: LLY) treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service
NHS Likely to Block Eli Lilly (NYSE: LLY) Alzheimer’s Treatment, The Telegraph Reports Read More »
NEW YORK – Older Americans are having little success getting prescriptions for the weight-loss drug Wegovy covered by Medicare despite
Doctors Face Hurdles in Securing Wegovy for Older Americans with Heart Disease Read More »
Swiss drugmaker Roche plans to accelerate the development of its anti-obesity drugs to challenge rivals like Eli Lilly (NYSE: LLY)
Roche to Fast-track Anti-Obesity Drug Development to Compete with Rivals: FT Report Read More »
On Tuesday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) treatment for early Alzheimer’s, making it the
Eli Lilly (NYSE: LLY) Secures FDA Approval for Alzheimer’s Drug Read More »
Eli Lilly and Company (NYSE: LLY) has reached an agreement to buy DICE Therapeutics, Inc. (NASDAQ: DICE). Eli Lilly will
Eli Lilly and Company (LLY) to Purchase DICE Therapeutics (DICE) for $2.4 Billion Read More »
Copyright © 2025 abbonews.com
